NCT01605981 - Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase. | Biotech Hunter

Timeline

Start Date

February 28, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Chronic Myeloid Leukemia (CML)

Interventions

DRUG

AMN107

Trial Locations (18)

24030210

Novartis Investigative Site, Niterói

60115-290

Novartis Investigative Site, Fortaleza

74605-020

Novartis Investigative Site, Goiânia

033426-102

Novartis Investigative Site, Cuiaba

30130-100

Novartis Investigative Site, Belo Horizonte

80060-900

Novartis Investigative Site, Curitiba

Unknown

Novartis Investigative Site, Porto Alegre

20.211-030

Novartis Investigative Site, Rio de Janeiro

90035-903

Novartis Investigative Site, Porto Alegre

88034-000

Novartis Investigative Site, Florianópolis

13083-970

Novartis Investigative Site, Campinas

17210-080

Novartis Investigative Site, Jaú

09190-615

Novartis Investigative Site, Santo André

11075-350

Novartis Investigative Site, Santos

15015-110

Novartis Investigative Site, São José

05651-901

Novartis Investigative Site, São Paulo

08270-070

Novartis Investigative Site, São Paulo

03454-000

Novartis Investigative Site, São Paulo